The global In-Vitro Diagnostics (IVDs) Medical Device Market was valued at approximately USD 86 billion in 2024 and is projected to reach USD 135 billion by 2034, growing at a CAGR of 4.8% over the ...
Tempus AI (TEM) stock has soared past $100, giving a 60% boost to billionaire Cliff Asness' TEM position in the AI-diagnostic ...
RALEIGH, N.C.--(BUSINESS WIRE)--Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry, announced today that it has acquired an ...
Tempus AI, Inc. (NASDAQ:TEM) is one of the best Nancy Pelosi stocks to buy right now. On September 22, the company received ...
Dublin, Nov. 13, 2020 (GLOBE NEWSWIRE) -- The "Medical Device & IVD Regulatory Affairs Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030" report has ...
More Lenient Guidelines May Inadvertently Lead to a Scarcity of Consented Samples Recently, no area has contributed more and increasingly complex layers to the bioethics debate than research employing ...
The Global IVD Contract Manufacturing Services Market valued at $4.6 billion (2021) is set to witness a growth rate of 4% by 2026. Growing preference for point-of-care (POC) testing services, Covid-19 ...
Zacks Investment Research on MSN
Tempus AI Enhances Cancer Research Tools With FDA-Cleared xR IVD
RNA sequencing provides a comprehensive view of biological information, offering deeper insights into disease mechanisms, including improved fusion detection. As a powerful tool in research and ...
Collaboration focuses on blood filters, leukoreduction, cleanroom assembly, and disposable medical manufacturing in ISO 7 & ISO 8 cleanrooms. By working with THY Precision (Hong Yang Precision), we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback